Premorbid obesity, but not nutrition, prevents critical illness‐induced muscle wasting and weakness
暂无分享,去创建一个
G. Van den Berghe | T. Janssens | F. Güiza | I. Vanhorebeek | G. Hermans | L. Langouche | K. De Bock | C. Goossens | T. Dufour | S. Vander Perre | S. Derde | S. Thiessen | M. Marques | Katrien De Bock
[1] M. Luedi. Journal of Cachexia, Sarcopenia and Muscle , 2019 .
[2] C. Hough,et al. ICU-Acquired Weakness. , 2016, Chest.
[3] S. Anker,et al. Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015 , 2015, Journal of cachexia, sarcopenia and muscle.
[4] Rahul Phadke,et al. Qualitative Ultrasound in Acute Critical Illness Muscle Wasting , 2015, Critical care medicine.
[5] F. Azizi,et al. Obesity Paradox and Risk of Mortality Events in Chronic Kidney Disease Patients: A Decade of Follow-up in Tehran Lipid and Glucose Study. , 2015, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
[6] M. Singer,et al. Detailed Characterization of a Long-Term Rodent Model of Critical Illness and Recovery , 2015, Critical care medicine.
[7] G. Van den Berghe,et al. Metabolic and nutritional support of critically ill patients: consensus and controversies , 2015, Critical Care.
[8] R. Deckelbaum,et al. In vivo handling and metabolism of lipid emulsions. , 2015, World review of nutrition and dietetics.
[9] W. Chan,et al. Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study. , 2014, Journal of the American College of Cardiology.
[10] R. Powers,et al. Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia , 2014, Cancer & metabolism.
[11] Avinash B. Kumar,et al. Obesity and perioperative acute kidney injury: a focused review. , 2014, Journal of critical care.
[12] C. Lavie,et al. Obesity paradox, cachexia, frailty, and heart failure. , 2014, Heart failure clinics.
[13] S. von Haehling. ICU-acquired weakness and recovery from critical illness. , 2014, The New England journal of medicine.
[14] James A. Nathan,et al. Muscle wasting in disease: molecular mechanisms and promising therapies , 2014, Nature Reviews Drug Discovery.
[15] Laura Antanas,et al. Charisma: An integrated approach to automatic H&E-stained skeletal muscle cell segmentation using supervised learning and novel robust clump splitting , 2013, Medical Image Anal..
[16] Rahul Phadke,et al. Acute skeletal muscle wasting in critical illness. , 2013, JAMA.
[17] G. Van den Berghe,et al. Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial. , 2013, The Lancet. Respiratory medicine.
[18] G. Van den Berghe,et al. Critical illness induces nutrient-independent adipogenesis and accumulation of alternatively activated tissue macrophages , 2013, Critical Care.
[19] Niels Peek,et al. Body Mass Index Is Associated With Hospital Mortality in Critically Ill Patients: An Observational Cohort Study , 2013, Critical care medicine.
[20] Dina Demner-Fushman,et al. Lower short- and long-term mortality associated with overweight and obesity in a large cohort study of adult intensive care unit patients , 2012, Critical Care.
[21] A. Molina,et al. Catabolic Signaling Pathways, Atrogenes, and Ubiquitinated Proteins Are Regulated by the Nutritional Status in the Muscle of the Fine Flounder , 2012, PloS one.
[22] G. Van den Berghe,et al. Early parenteral nutrition evokes a phenotype of autophagy deficiency in liver and skeletal muscle of critically ill rabbits. , 2012, Endocrinology.
[23] J. Wernerman,et al. Protein metabolism and gene expression in skeletal muscle of critically ill patients with sepsis. , 2012, Clinical science.
[24] Sarah Derde,et al. Muscle atrophy and preferential loss of myosin in prolonged critically ill patients* , 2012, Critical care medicine.
[25] G. Van den Berghe,et al. Early versus Late Parenteral Nutrition in Critically Ill Adults , 2011, The New England journal of medicine.
[26] J. Schefold,et al. Intensive care unit—acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock , 2010, Journal of cachexia, sarcopenia and muscle.
[27] Z. Puthucheary,et al. Skeletal muscle dysfunction in critical care: Wasting, weakness, and rehabilitation strategies , 2010, Critical care medicine.
[28] Raphaël Porcher,et al. Propensity scores in intensive care and anaesthesiology literature: a systematic review , 2010, Intensive Care Medicine.
[29] R. Griffiths,et al. Intensive care unit-acquired weakness , 2010, Critical care medicine.
[30] G. Van den Berghe,et al. Increasing intravenous glucose load in the presence of normoglycemia: Effect on outcome and metabolism in critically ill rabbits , 2010, Critical care medicine.
[31] P. Pronovost,et al. The impact of obesity on outcomes after critical illness: a meta-analysis , 2009, Intensive Care Medicine.
[32] Md. Razaul Karim,et al. Cytosolic LC3 ratio as a quantitative index of macroautophagy. , 2009, Methods in enzymology.
[33] A. E. El Solh,et al. Effect of obesity on intensive care morbidity and mortality: A meta-analysis* , 2008, Critical care medicine.
[34] Masaaki Komatsu,et al. Homeostatic Levels of p62 Control Cytoplasmic Inclusion Body Formation in Autophagy-Deficient Mice , 2007, Cell.
[35] P. Pronovost,et al. Neuromuscular dysfunction acquired in critical illness: a systematic review , 2007, Intensive Care Medicine.
[36] G. Fonarow,et al. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. , 2007, American heart journal.
[37] Sandra L. Peake,et al. The effect of obesity on 12-month survival following admission to intensive care: A prospective study* , 2006, Critical care medicine.
[38] I. Vanhorebeek,et al. Endocrine aspects of acute and prolonged critical illness , 2006, Nature Clinical Practice Endocrinology &Metabolism.
[39] Ilse Vanhorebeek,et al. Intensive insulin therapy protects the endothelium of critically ill patients. , 2005, The Journal of clinical investigation.
[40] G. Van den Berghe,et al. Hormonal and metabolic strategies to attenuate catabolism in critically ill patients. , 2004, Current opinion in pharmacology.
[41] J. Horton,et al. Molecular mediators of hepatic steatosis and liver injury. , 2004, The Journal of clinical investigation.
[42] V. P. Misra,et al. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness* , 2003, Critical care medicine.
[43] A. Goldberg,et al. Patterns of gene expression in atrophying skeletal muscles: response to food deprivation , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[44] A. Bach,et al. Structure and metabolic fate of triacylglycerol- and phospholipid-rich particles of commercial parenteral fat emulsions. , 1999, Nutrition.
[45] H. Phetteplace,et al. Sepsis-induced regulation of lipoprotein lipase expression in rat adipose tissue and soleus muscle. , 1997, Journal of lipid research.
[46] J. Rodin,et al. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. , 1995, Metabolism: clinical and experimental.
[47] L. Chan,et al. Endotoxin-induced hypertriglyceridemia is mediated by suppression of lipoprotein lipase at a post-transcriptional level. , 1993, Journal of lipid research.
[48] M. Ulmer,et al. Paradoxical effect of ethanol on liver lipogenesis in the genetically-obese Zucker rat , 1985, British Journal of Nutrition.
[49] S H Rosenbaum,et al. Influence of total parenteral nutrition on fuel utilization in injury and sepsis. , 1980, Annals of surgery.
[50] D. Williamson,et al. Physiological roles of ketone bodies as substrates and signals in mammalian tissues. , 1980, Physiological reviews.
[51] P. Björntorp,et al. Plasma free fatty acid turnover rate in obesity. , 2009, Acta medica Scandinavica.